Deborah R. Erickson, MD

Practice areas

Practice areas

Clinical interests

  • Extracorporeal Shock Wave Lithotripsy
  • Female Urology
  • Neurourology
  • Voiding Dysfunction

Deborah R. Erickson, MD

Biography

My name is Deborah Erickson; I received my medical degree from the University of Missouri - Columbia, School of Medicine, Columbia. I completed a fellowship in Female Urology and Neurology at the University of California Hospital, Los Angeles.

I am board certified by the American Board of Urology.

Faculty rank

Professor of Urology

Education

Degree
University of Missouri - Columbia, School of Medicine, Columbia

Residency
University of Texas Health Science Center, San Antonio

Fellowship
Female Urology and Neurology, University of California Hospital, Los Angeles

Certifications or Special training
American Board of Urology

Urology

Kentucky Clinic
Second Floor, Wing C, Room B200
740 S. Limestone
Lexington KY 40536-0284

Call 859-257-3533
Fax 859-257-6024

Amenities
Dining, Internet/Wi-Fi, Information desk, Pharmacy services, Wheelchairs

Kentucky Clinic Map (PDF, 616 KB) »
Directions to Kentucky Clinic Parking »


UK HealthCare accepts many forms of insurance. See list of insurers »

 
  1. Erickson DR. Paradoxical consequences and electronic notes. J Urol. 2013 Mar; 189(3):793-5. PMID: 23276512.
    View in: PubMed
  2. Quillin RB, Erickson DR. Practical use of the newAmerican Urological Association interstitial cystitis guidelines. Curr Urol Rep. 2012 Oct; 13(5):394-401. PMID: 22828913.
    View in: PubMed
  3. Forrest JB, Payne CK, Erickson DR. Cyclosporine A for refractory interstitial cystitis/bladder pain syndrome: experience of 3 tertiary centers. J Urol. 2012 Oct; 188(4):1186-91. PMID: 22901569.
    View in: PubMed
  4. Quillin RB, Erickson DR. Management of interstitial cystitis/bladder pain syndrome: a urology perspective. Urol Clin North Am. 2012 Aug; 39(3):389-96. PMID: 22877722.
    View in: PubMed
  5. Rogers WB, Erickson DR. Early adoption of new devices: flying on untested wings. J Urol. 2012 Mar; 187(3):783-4. PMID: 22248513.
    View in: PubMed
  6. Blalock EM, Korrect GS, Stromberg AJ, Erickson DR. Gene expression analysis of urine sediment: evaluation for potential noninvasive markers of interstitial cystitis/bladder pain syndrome. J Urol. 2012 Feb; 187(2):725-32. PMID: 22177197.
    View in: PubMed
  7. Erickson DR. Safety and errors: a lesson from the airlines. J Urol. 2011 Oct; 186(4):1177-8. PMID: 21849195.
    View in: PubMed
  8. Hanno PM, Burks DA, Clemens JQ, Dmochowski RR, Erickson D, Fitzgerald MP, Forrest JB, Gordon B, Gray M, Mayer RD, Newman D, Nyberg L, Payne CK, Wesselmann U, Faraday MM. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2011 Jun; 185(6):2162-70. PMID: 21497847.
    View in: PubMed
  9. Erickson DR, Boulanger B. Patient safety: above and beyond the checklist. J Urol. 2011 Apr; 185(4):1177-8. PMID: 21334690.
    View in: PubMed
  10. Erickson DR. Are urodynamics needed before surgery for straightforward female stress incontinence? J Urol. 2010 Dec; 184(6):2237-8. PMID: 20961583.
    View in: PubMed
  11. Erickson DR. Menopausal hormone therapy--why do different studies have different results for the same outcome? J Urol. 2009 Oct; 182(4):1251-2. PMID: 19683306.
    View in: PubMed
  12. Erickson DR. The placebo response. J Urol. 2009 Mar; 181(3):945-6. PMID: 19150566.
    View in: PubMed
  13. Erickson DR, Schwarze SR, Dixon JK, Clark CJ, Hersh MA. Differentiation associated changes in gene expression profiles of interstitial cystitis and control urothelial cells. J Urol. 2008 Dec; 180(6):2681-7. PMID: 18951569.
    View in: PubMed
  14. Erickson DR. The use of mesh for pelvic reconstruction--how much, what type and where? J Urol. 2008 Jul; 180(1):8-9. PMID: 18485381.
    View in: PubMed
  15. Erickson DR, Tomaszewski JE, Kunselman AR, Stetter CM, Peters KM, Rovner ES, Demers LM, Wheeler MA, Keay SK. Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome. J Urol. 2008 May; 179(5):1850-6. PMID: 18353383.
    View in: PubMed
  16. Erickson DR. Learning objectives. J Urol. 2008 Apr; 179(4):1222. PMID: 18280510.
    View in: PubMed
  17. Erickson DR, Propert KJ. Pregnancy and interstitial cystitis/painful bladder syndrome. Urol Clin North Am. 2007 Feb; 34(1):61-9. PMID: 17145362.
    View in: PubMed
  18. Erickson DR, Kunselman AR, Bentley CM, Peters KM, Rovner ES, Demers LM, Wheeler MA, Keay SK. Changes in urine markers and symptoms after bladder distention for interstitial cystitis. J Urol. 2007 Feb; 177(2):556-60. PMID: 17222633.
    View in: PubMed
  19. Erickson DR, Sheykhnazari M, Bhavanandan VP. Molecular size affects urine excretion of pentosan polysulfate. J Urol. 2006 Mar; 175(3 Pt 1):1143-7. PMID: 16469641.
    View in: PubMed
  20. Muthusamy A, Erickson DR, Sheykhnazari M, Bhavanandan VP. Enhanced binding of modified pentosan polysulfate and heparin to bladder--a strategy for improved treatment of interstitial cystitis. Urology. 2006 Jan; 67(1):209-13. PMID: 16413377.
    View in: PubMed
  21. Erickson DR, Tomaszewski JE, Kunselman AR, Bentley CM, Peters KM, Rovner ES, Demers LM, Wheeler MA, Keay SK. Do the National Institute of Diabetes and Digestive and Kidney Diseases cystoscopic criteria associate with other clinical and objective features of interstitial cystitis? J Urol. 2005 Jan; 173(1):93-7. PMID: 15592040.
    View in: PubMed
  22. Erickson DR, Kunselman AR, Bentley CM, Peters KM, Rovner ES, Demers LM, Tomaszewski JE. Is urine methylhistamine a useful marker for interstitial cystitis? J Urol. 2004 Dec; 172(6 Pt 1):2256-60. PMID: 15538243.
    View in: PubMed
  23. Erickson D, Kunselman A, Bentley C. Re: an interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol. 2003 Oct; 170(4 Pt 1):1326-7; author reply 1327. PMID: 14501760.
    View in: PubMed
  24. u Zhang CO, Li ZL, Shoenfelt JL, Kong CZ, Chai TC, Erickson DR, Peters KM, Rovner ES, Keay S. Comparison of APF activity and epithelial growth factor levels in urine from Chinese, African-American, and white American patients with interstitial cystitis. Urology. 2003 May; 61(5):897-901. PMID: 12735999.
    View in: PubMed
  25. Erickson DR, Xie SX, Bhavanandan VP, Wheeler MA, Hurst RE, Demers LM, Kushner L, Keay SK. A comparison of multiple urine markers for interstitial cystitis. J Urol. 2002 Jun; 167(6):2461-9. PMID: 11992058.
    View in: PubMed
  26. Erickson DR, Morgan KC, Ordille S, Keay SK, Xie SX. Nonbladder related symptoms in patients with interstitial cystitis. J Urol. 2001 Aug; 166(2):557-61; discussion 561-2. PMID: 11458068.
    View in: PubMed
  27. Erickson DR. Urine markers of interstitial cystitis. Urology. 2001 Jun; 57(6 Suppl 1):15-21. PMID: 11378044.
    View in: PubMed
  28. Keay SK, Zhang CO, Shoenfelt J, Erickson DR, Whitmore K, Warren JW, Marvel R, Chai T. Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis. Urology. 2001 Jun; 57(6 Suppl 1):9-14. PMID: 11378043.
    View in: PubMed
  29. Erickson DR, Herb N, Ordille S, Harmon N, Bhavanandan VP. A new direct test of bladder permeability. J Urol. 2000 Aug; 164(2):419-22. PMID: 10893600.
    View in: PubMed
  30. Higuchi T, Xin P, Buckley MS, Erickson DR, Bhavanandan VP. Characterization of the rabbit homolog of human MUC1 glycoprotein isolated from bladder by affinity chromatography on immobilized jacalin. Glycobiology. 2000 Jul; 10(7):659-67. PMID: 10910971.
    View in: PubMed
  31. Erickson DR, Sheykhnazari M, Ordille S, Bhavanandan VP. Increased urinary hyaluronic acid and interstitial cystitis. J Urol. 1998 Oct; 160(4):1282-4. PMID: 9751336.
    View in: PubMed
  32. Bhavanandan VP, Erickson DR. An investigation of the nature of bladder mucosal glycoconjugates and their role in interstitial cystitis. Indian J Biochem Biophys. 1997 Feb-Apr; 34(1-2):205-11. PMID: 9343952.
    View in: PubMed
  33. Erickson DR, Ordille S, Martin A, Bhavanandan VP. Urinary chondroitin sulfates, heparan sulfate and total sulfated glycosaminoglycans in interstitial cystitis. J Urol. 1997 Jan; 157(1):61-4. PMID: 8976216.
    View in: PubMed
  34. Erickson DR, Mast S, Ordille S, Bhavanandan VP. Urinary epitectin (MUC-1 glycoprotein) in the menstrual cycle and interstitial cystitis. J Urol. 1996 Sep; 156(3):938-42. PMID: 8709368.
    View in: PubMed
  35. Bhavanandan VP, Martin A, Erickson DR. Quantitation of urinary glycosaminoglycans with Alcian blue: evaluation of the interference by Tamm-Horsfall glycoprotein. Clin Chim Acta. 1996 Jul 30; 251(2):207-14. PMID: 8862475.
    View in: PubMed
  36. Erickson DR, Simon LJ, Belchis DA. Relationships between bladder inflammation and other clinical features in interstitial cystitis. Urology. 1994 Nov; 44(5):655-9. PMID: 7974939.
    View in: PubMed
  37. Erickson DR, Hlavinka TC, Rockwood AP, Metter JD, Novicki DE, Fried MG. Prostatic acid phosphatase, beta-glucuronidase and prostate specific antigen assays in fine needle aspirates from benign and malignant prostates. J Urol. 1991 Nov; 146(5):1402-7. PMID: 1719247.
    View in: PubMed
  38. Sarosdy MF, Hudnall CH, Erickson DR, Hardin TC, Novicki DE. A prospective double-blind trial of intracorporeal papaverine versus prostaglandin E1 in the treatment of impotence. J Urol. 1989 Mar; 141(3):551-3. PMID: 2645420.
    View in: PubMed